Assessment of the cellular internalization of thermolytic phosphorothioate DNA oligonucleotide prodrugs

The bioactivity of a CpG-containing phosphorothioate DNA oligonucleotide with thermolytic 2-(N-formyl-N-methylamino)ethyl (fma) thiophosphate groups in mice led us to investigate the parameters affecting the internalization of these thermosensitive DNA prodrugs in various cell lines. Flow cytometry...

Full description

Saved in:
Bibliographic Details
Published inBioorganic & medicinal chemistry Vol. 21; no. 20; pp. 6224 - 6232
Main Authors Jain, Harsh V., Takeda, Kazuyo, Tami, Cecilia, Verthelyi, Daniela, Beaucage, Serge L.
Format Journal Article
LanguageEnglish
Published OXFORD Elsevier Ltd 15.10.2013
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The bioactivity of a CpG-containing phosphorothioate DNA oligonucleotide with thermolytic 2-(N-formyl-N-methylamino)ethyl (fma) thiophosphate groups in mice led us to investigate the parameters affecting the internalization of these thermosensitive DNA prodrugs in various cell lines. Flow cytometry and confocal microscopy analyses indicate that 5′-fluoresceinated fma-phosphorothioate DNA sequences are poorly internalized in Vero, HeLa and GC-2 cells. However, when four fma-thiophosphate groups of a 15-nucleotide long oligothymidylate prodrug are replaced with 3-(N,N-dimethylamino)prop-1-yl thiophosphate functions, internalization of the positively charged prodrug, under physiological conditions, increased fourfold in HeLa and 40-fold in Vero or GC-2 cells. No cytotoxic effects are observed in Vero cells even at an extracellular prodrug concentration of 50μM over a period of 72h. Confocal microscopy studies show that internalization of the positively charged oligothymidylate prodrug in Vero cells is time-dependent with early trafficking of the DNA sequence through endosomal vesicles and, eventually, to the nucleus of the cells. Thus, the incorporation of four 3-(N,N-dimethylamino)prop-1-yl thiophosphate groups into thermosentive fma-phosphorothioate DNA prodrugs is an attractive strategy for efficient cellular internalization of these nucleic acid-based drugs for potential therapeutic indications.
AbstractList The bioactivity of a CpG-containing phosphorothioate DNA oligonucleotide with thermolytic 2-(N-formyl-N-methylamino)ethyl (fma) thiophosphate groups in mice led us to investigate the parameters affecting the internalization of these thermosensitive DNA prodrugs in various cell lines. Flow cytometry and confocal microscopy analyses indicate that 5′-fluoresceinated fma-phosphorothioate DNA sequences are poorly internalized in Vero, HeLa and GC-2 cells. However, when four fma-thiophosphate groups of a 15-nucleotide long oligothymidylate prodrug are replaced with 3-(N,N-dimethylamino)prop-1-yl thiophosphate functions, internalization of the positively charged prodrug, under physiological conditions, increased fourfold in HeLa and 40-fold in Vero or GC-2 cells. No cytotoxic effects are observed in Vero cells even at an extracellular prodrug concentration of 50μM over a period of 72h. Confocal microscopy studies show that internalization of the positively charged oligothymidylate prodrug in Vero cells is time-dependent with early trafficking of the DNA sequence through endosomal vesicles and, eventually, to the nucleus of the cells. Thus, the incorporation of four 3-(N,N-dimethylamino)prop-1-yl thiophosphate groups into thermosentive fma-phosphorothioate DNA prodrugs is an attractive strategy for efficient cellular internalization of these nucleic acid-based drugs for potential therapeutic indications.
The bioactivity of a CpG-containing phosphorothioate DNA oligonucleotide with thermolytic 2-(N-formyl-N-methylamino)ethyl (fma) thiophosphate groups in mice led us to investigate the parameters affecting the internalization of these thermosensitive DNA prodrugs in various cell lines. Flow cytometry and confocal microscopy analyses indicate that 5'-fluoresceinated fma-phosphorothioate DNA sequences are poorly internalized in Vero, HeLa and GC-2 cells. However, when four fma-thiophosphate groups of a 15-nucleotide long oligothymidylate prodrug are replaced with 3-(N,N-dimethylamino)prop-1-yl thiophosphate functions, internalization of the positively charged prodrug, under physiological conditions, increased fourfold in HeLa and 40-fold in Vero or GC-2 cells. No cytotoxic effects are observed in Vero cells even at an extracellular prodrug concentration of 50 μM over a period of 72 h. Confocal microscopy studies show that internalization of the positively charged oligothymidylate prodrug in Vero cells is time-dependent with early trafficking of the DNA sequence through endosomal vesicles and, eventually, to the nucleus of the cells. Thus, the incorporation of four 3-(N,N-dimethylamino)prop-1-yl thiophosphate groups into thermosentive fma-phosphorothioate DNA prodrugs is an attractive strategy for efficient cellular internalization of these nucleic acid-based drugs for potential therapeutic indications.
The bioactivity of a CpG-containing phosphorothioate DNA oligonucleotide with thermolytic 2-(N-formyl-N-methylamino) ethyl (fma) thiophosphate groups in mice led us to investigate the parameters affecting the internalization of these thermosensitive DNA prodrugs in various cell lines. Flow cytometry and confocal microscopy analyses indicate that 5'-fluoresceinated fma-phosphorothioate DNA sequences are poorly internalized in Vero, HeLa and GC-2 cells. However, when four fma-thiophosphate groups of a 15-nucleotide long oligothymidylate prodrug are replaced with 3-(N, N-dimethylamino) prop-1-yl thiophosphate functions, internalization of the positively charged prodrug, under physiological conditions, increased fourfold in HeLa and 40-fold in Vero or GC-2 cells. No cytotoxic effects are observed in Vero cells even at an extracellular prodrug concentration of 50 mu M over a period of 72 h. Confocal microscopy studies show that internalization of the positively charged oligothymidylate prodrug in Vero cells is time-dependent with early trafficking of the DNA sequence through endosomal vesicles and, eventually, to the nucleus of the cells. Thus, the incorporation of four 3-(N, N-dimethylamino) prop-1-yl thiophosphate groups into thermosentive fma-phosphorothioate DNA prodrugs is an attractive strategy for efficient cellular internalization of these nucleic acid-based drugs for potential therapeutic indications. Published by Elsevier Ltd.
The bioactivity of a CpG-containing phosphorothioate DNA oligonucleotide with thermolytic 2-(N-formyl-N-methylamino)ethyl (fma) thiophosphate groups in mice led us to investigate the parameters affecting the internalization of these thermosensitive DNA prodrugs in various cell lines. Flow cytometry and confocal microscopy analyses indicate that 5'-fluoresceinated fma-phosphorothioate DNA sequences are poorly internalized in Vero, HeLa and GC-2 cells. However, when four fma-thiophosphate groups of a 15-nucleotide long oligothymidylate prodrug are replaced with 3-(N,N-dimethylamino)prop-1-yl thiophosphate functions, internalization of the positively charged prodrug, under physiological conditions, increased fourfold in HeLa and 40-fold in Vero or GC-2 cells. No cytotoxic effects are observed in Vero cells even at an extracellular prodrug concentration of 50 mu M over a period of 72 h. Confocal microscopy studies show that internalization of the positively charged oligothymidylate prodrug in Vero cells is time-dependent with early trafficking of the DNA sequence through endosomal vesicles and, eventually, to the nucleus of the cells. Thus, the incorporation of four 3-(N,N-dimethylamino)prop-1-yl thiophosphate groups into thermosentive fma-phosphorothioate DNA prodrugs is an attractive strategy for efficient cellular internalization of these nucleic acid-based drugs for potential therapeutic indications.
Author Beaucage, Serge L.
Verthelyi, Daniela
Tami, Cecilia
Jain, Harsh V.
Takeda, Kazuyo
Author_xml – sequence: 1
  givenname: Harsh V.
  surname: Jain
  fullname: Jain, Harsh V.
  organization: Laboratory of Chemistry, FDA-CDER, 8800 Rockville Pike, Bethesda, MD 20892, USA
– sequence: 2
  givenname: Kazuyo
  surname: Takeda
  fullname: Takeda, Kazuyo
  organization: Confocal Microscopy Core Facility, FDA-CBER, 8800 Rockville Pike, Bethesda, MD 20892, USA
– sequence: 3
  givenname: Cecilia
  surname: Tami
  fullname: Tami, Cecilia
  organization: Laboratory of Immunology, FDA-CDER, 8800 Rockville Pike, Bethesda, MD 20892, USA
– sequence: 4
  givenname: Daniela
  surname: Verthelyi
  fullname: Verthelyi, Daniela
  organization: Laboratory of Immunology, FDA-CDER, 8800 Rockville Pike, Bethesda, MD 20892, USA
– sequence: 5
  givenname: Serge L.
  surname: Beaucage
  fullname: Beaucage, Serge L.
  email: serge.beaucage@fda.hhs.gov
  organization: Laboratory of Chemistry, FDA-CDER, 8800 Rockville Pike, Bethesda, MD 20892, USA
BackLink https://www.ncbi.nlm.nih.gov/pubmed/23755885$$D View this record in MEDLINE/PubMed
BookMark eNqNkUuP0zAUhS00iOkM_AA2kCUSSvEzscWqKk9pBAuYteU4162rJC62Axp-PS4pswQWlm3d7xz73nOFLqYwAUJPCV4TTJpXh3U32jXFhK0xX-OWPEArwhteM6bIBVph1cgaS9VcoquUDhhjyhV5hC4pa4WQUqzQbpMSpDTClKvgqryHysIwzIOJlZ8yxMkM_qfJPkznehzDcJe9rY77kMqKIe99MBmqN582VRj8LkyzHSBk30N1jKGP8y49Rg-dGRI8Oe_X6Pbd26_bD_XN5_cft5ub2vK2yTWYninata0kQnQdl9TwVsjeNapjLekIZcS0DsrFYdpJ46xSpnHOQit4D-wavVh8y8PfZkhZjz6dOjIThDlpIihmUjHO_40WhknZKFxQsqA2hpQiOH2MfjTxThOsT1Hogy5R6FMUGnNdoiiaZ2f7uRuhv1f8mX0B5AL8gC64ZD1MFu6xEhajgjS0HDBRW59_h7AN85SL9OX_Swv9fKGdCdrsok_69kv5qihVQhg7jeL1QkCJ5ruHqM-evY9gs-6D_0unvwAjDscw
CitedBy_id crossref_primary_10_1016_j_bmcl_2015_03_064
crossref_primary_10_1021_acs_orglett_8b03501
crossref_primary_10_3762_bjoc_14_32
crossref_primary_10_1002_cbic_201402382
crossref_primary_10_1016_j_bmc_2015_07_054
crossref_primary_10_1039_C5RA12038A
crossref_primary_10_1002_cpnc_51
crossref_primary_10_1002_0471142700_nc0469s64
crossref_primary_10_1016_j_bmcl_2015_11_064
crossref_primary_10_1248_cpb_c17_00696
crossref_primary_10_1021_acs_bioconjchem_6b00368
Cites_doi 10.1002/anie.200500904
10.1021/jo062087y
10.1016/j.addr.2007.10.016
10.1021/bc049977+
10.1021/ar200131t
10.1016/j.chembiol.2012.07.011
10.1517/17425247.2011.561313
10.1007/s00018-009-0186-0
10.1002/cyto.a.20139
10.1093/nar/gki657
10.1046/j.1432-1033.2003.03555.x
10.1007/s10709-009-9405-8
10.1002/path.2993
10.1124/pr.58.1.8
10.1093/nar/gkg733
10.1021/mp900093r
10.1002/cbic.200500433
10.1089/108729002753670247
10.1021/ol0156852
10.3109/08982109709035481
10.1038/78523
10.1016/0960-894X(95)00074-4
10.1073/pnas.97.24.13003
10.1089/108729002760070849
10.1093/nar/27.20.4071
10.1016/S0169-409X(99)00034-4
10.1021/bc0000334
10.4161/cbt.1.4.4
10.2174/1389201043376706
10.1146/annurev.pharmtox.41.1.403
10.1074/jbc.270.52.31391
10.1089/108729002760070795
10.1093/nar/22.20.4268
10.4049/jimmunol.162.4.2291
10.1016/S0005-2736(97)00194-6
10.1248/bpb.28.886
10.1034/j.1399-3011.2000.00723.x
ContentType Journal Article
Copyright 2013
Published by Elsevier Ltd.
Copyright_xml – notice: 2013
– notice: Published by Elsevier Ltd.
DBID FBQ
1KM
BLEPL
DTL
GKMDS
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
7QO
7TM
8FD
FR3
P64
DOI 10.1016/j.bmc.2013.04.071
DatabaseName AGRIS
Index Chemicus
Web of Science Core Collection
Science Citation Index Expanded
Web of Science - Science Citation Index Expanded - 2013
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
Biotechnology Research Abstracts
Nucleic Acids Abstracts
Technology Research Database
Engineering Research Database
Biotechnology and BioEngineering Abstracts
DatabaseTitle Web of Science
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
Engineering Research Database
Biotechnology Research Abstracts
Technology Research Database
Nucleic Acids Abstracts
Biotechnology and BioEngineering Abstracts
DatabaseTitleList

MEDLINE
MEDLINE - Academic
Web of Science
Engineering Research Database
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 1KM
  name: Index Chemicus
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/woscc/search-with-editions?editions=WOS.IC
  sourceTypes:
    Enrichment Source
    Index Database
– sequence: 3
  dbid: FBQ
  name: AGRIS
  url: http://www.fao.org/agris/Centre.asp?Menu_1ID=DB&Menu_2ID=DB1&Language=EN&Content=http://www.fao.org/agris/search?Language=EN
  sourceTypes: Publisher
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Anatomy & Physiology
Chemistry
EISSN 1464-3391
EndPage 6232
ExternalDocumentID 10_1016_j_bmc_2013_04_071
23755885
000325162000019
US201500111334
S0968089613004100
Genre Research Support, U.S. Gov't, Non-P.H.S
Research Support, U.S. Gov't, P.H.S
Journal Article
GrantInformation_xml – fundername: Postgraduate Research Participation Program at the Center for Drug Evaluation and Research
GroupedDBID ---
--K
--M
.~1
0R~
1B1
1RT
1~.
1~5
23N
4.4
457
4G.
5GY
5VS
7-5
71M
8P~
9JM
9JN
AABNK
AACTN
AAEDT
AAEDW
AAIAV
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AARLI
AATCM
AAXUO
ABBQC
ABFNM
ABGSF
ABJNI
ABLVK
ABMAC
ABMZM
ABUDA
ABXDB
ABYKQ
ABZDS
ACDAQ
ACGFS
ACIUM
ACRLP
ADBBV
ADECG
ADEZE
ADUVX
AEBSH
AEHWI
AEKER
AENEX
AFKWA
AFTJW
AFXIZ
AFZHZ
AGUBO
AGYEJ
AHHHB
AIEXJ
AIKHN
AITUG
AJBFU
AJOXV
AJRQY
AJSZI
ALCLG
ALMA_UNASSIGNED_HOLDINGS
AMFUW
AMRAJ
ANZVX
AXJTR
BKOJK
BLXMC
BNPGV
CS3
DOVZS
DU5
EBS
EFJIC
EFLBG
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FIRID
FLBIZ
FNPLU
FYGXN
G-Q
GBLVA
IHE
J1W
KOM
LCYCR
LZ2
M29
M2Z
M34
M41
MO0
N9A
O-L
O9-
OAUVE
OGGZJ
OZT
P-8
P-9
P2P
PC.
Q38
RIG
ROL
RPZ
SCC
SDF
SDG
SDP
SES
SPC
SPCBC
SSH
SSK
SSP
SSU
SSZ
T5K
UPT
XPP
YK3
~02
~G-
53G
AAQXK
ABPIF
ABPTK
ACNNM
ADMUD
AFFNX
AGHFR
AGRDE
ASPBG
AVWKF
AZFZN
FBQ
FEDTE
FGOYB
G-2
HEA
HMK
HMO
HMS
HMT
HVGLF
HZ~
R2-
SAE
SCB
SEW
SOC
SPT
WUQ
ZMT
1KM
AAXKI
AKRWK
BLEPL
DTL
GROUPED_WOS_SCIENCE_CITATION_INDEX_EXPANDED
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
7QO
7TM
8FD
FR3
P64
ID FETCH-LOGICAL-c476t-ead392b778155bb482a4758df69b371b1231a7feb37f02b8afc99a6ffce754de3
IEDL.DBID .~1
ISICitedReferencesCount 9
ISICitedReferencesURI https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestApp=WOS&DestLinkType=CitingArticles&UT=000325162000019
ISSN 0968-0896
IngestDate Fri Aug 16 22:47:35 EDT 2024
Fri Aug 16 22:40:21 EDT 2024
Thu Sep 12 16:48:13 EDT 2024
Thu May 23 23:17:06 EDT 2024
Wed Sep 18 06:48:42 EDT 2024
Wed Sep 18 03:38:29 EDT 2024
Wed Dec 27 19:01:14 EST 2023
Fri Feb 23 02:30:56 EST 2024
IsPeerReviewed true
IsScholarly true
Issue 20
Keywords Thermolytic DNA prodrugs
Nucleic acid-based drug delivery
fma-Thiophosphate protecting group
Nuclear localization
Cellular internalization
Positively charged DNA prodrug
TRANSPORTERS
TRAFFICKING
MECHANISMS
BIOLOGICAL BARRIERS
DELIVERY
LIPOPHILIC PRO-OLIGONUCLEOTIDES
PROTECTING GROUP
HELA-CELLS
ANTISENSE OLIGONUCLEOTIDES
BACTERIAL-DNA
Language English
License Published by Elsevier Ltd.
LinkModel DirectLink
LogoURL https://exlibris-pub.s3.amazonaws.com/fromwos-v2.jpg
MergedId FETCHMERGED-LOGICAL-c476t-ead392b778155bb482a4758df69b371b1231a7feb37f02b8afc99a6ffce754de3
Notes http://dx.doi.org/10.1016/j.bmc.2013.04.071
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Article-2
ObjectType-Feature-1
ORCID 0000-0001-8163-6219
PMID 23755885
PQID 1443388690
PQPubID 23479
PageCount 9
ParticipantIDs proquest_miscellaneous_1520389344
webofscience_primary_000325162000019CitationCount
fao_agris_US201500111334
crossref_primary_10_1016_j_bmc_2013_04_071
elsevier_sciencedirect_doi_10_1016_j_bmc_2013_04_071
proquest_miscellaneous_1443388690
pubmed_primary_23755885
webofscience_primary_000325162000019
PublicationCentury 2000
PublicationDate 2013-10-15
PublicationDateYYYYMMDD 2013-10-15
PublicationDate_xml – month: 10
  year: 2013
  text: 2013-10-15
  day: 15
PublicationDecade 2010
PublicationPlace OXFORD
PublicationPlace_xml – name: OXFORD
– name: England
PublicationTitle Bioorganic & medicinal chemistry
PublicationTitleAbbrev BIOORGAN MED CHEM
PublicationTitleAlternate Bioorg Med Chem
PublicationYear 2013
Publisher Elsevier Ltd
Elsevier
Publisher_xml – name: Elsevier Ltd
– name: Elsevier
References Luo, Saltzman (b0050) 2000; 18
Grajkowski, Ausín, Kauffman, Snyder, Hess, Lloyd, Beaucage (b0170) 2007; 72
Barber, Rayner, Imbach (b0100) 1995; 5
Tung, Stein (b0065) 2000; 11
Guy-Caffey, Bodepudi, Bishop, Jayaraman, Chaudhary (b0140) 1995; 270
Tonkinson, Stein (b0150) 1994; 22
Arora, Devi, Iversen (b0160) 2004; 5
Juliano, Bauman, Kang, Ming (b0035) 2009; 6
Wender, Galliher, Goun, Jones, Pillow (b0070) 2008; 60
Wender, Mitchell, Pattabiraman, Pelkey, Steinman, Rothbard (b0075) 2000; 97
Ohmichi, Kuwahara, Sasaki, Hasegawa, Nishikata, Sawai, Sugimoto (b0080) 2005; 44
Nuutila, Lilius (b0145) 2005; 65A
Hemmi, Takeuchi, Kawai, Kaisho, Sato, Sanjo, Matsumoto, Hoshino, Wagner, Takeda, Akira (b0130) 2000; 408
Elkins, Rhinehart-Jones, Stibitz, Conover, Klinman (b0125) 1999; 162
Prater, Miller (b0060) 2004; 15
Manoharan (b0095) 2002; 12
Said Hassane, Saleh, Abes, Gait, Lebleu (b0055) 2010; 67
Vivès, Dell’Aquila, Bologna, Morvan, Rayner, Imbach (b0110) 1999; 27
Li, Frederiksen, Piccirilli (b0045) 2011; 44
Lebedeva, Stein (b0040) 2001; 41
Nishimura, Naito (b0135) 2005; 28
Koppelhus, Awasthi, Zachar, Holst, Ebbesen, Nielsen (b0155) 2002; 12
Michel, Martinand-Maril, Debart, Lebleu, Robbins, Vasseur (b0090) 2003; 31
Khalil, Kogure, Akita, Harashima (b0020) 2006; 58
Mitchell, Kim, Steinman, Fathman, Rothbard (b0175) 2000; 56
Deglane, Abes, Michel, Prévot, Vives, Debart, Barvik, Lebleu, Vasseur (b0085) 2006; 7
Kurreck (b0015) 2003; 270
Dias, Stein (b0165) 2002; 1
Watts, Corey (b0010) 2012; 226
Ming (b0025) 2011; 8
Grajkowski, Wilk, Chmielewski, Phillips, Beaucage (b0115) 2001; 3
Deleavey, Damha (b0005) 2012; 19
Labas, Beilvert, Barteau, David, Chèvre, Pitard (b0185) 2010; 138
Bologna, Vivès, Imbach, Morvan (b0105) 2002; 12
Grajkowski, Pedras-Vasconcelos, Wang, Ausín, Hess, Verthelyi, Beaucage (b0120) 2005; 33
Bally, Harvie, Wong, Kong, Wasan, Reimer (b0030) 1999; 38
Escriou, Ciolina, Lacroix, Byk, Scherman, Wils (b0180) 1998; 1368
Litzinger (b0190) 1997; 7
Grajkowski, A (WOS:000168395400011) 2001; 3
Manoharan, M (WOS:000176064800006) 2002; 12
Watts, JK (WOS:000299157600018) 2012; 226
Deglane, G (WOS:000236685900019) 2006; 7
Litzinger, David C. (BCI:BCI199799461657) 1997; 7
Vives, E (WOS:000083201400015) 1999; 27
Ming, X (WOS:000288549600004) 2011; 8
Nishimura, M (WOS:000229083600023) 2005; 28
Khalil, IA (WOS:000235683400005) 2006; 58
Bally, MB (WOS:000082371300007) 1999; 38
Bologna, JC (WOS:000175215800004) 2002; 12
GuyCaffey, JK (WOS:A1995TN44400080) 1995; 270
Grajkowski, A (WOS:000230345800017) 2005; 33
Luo, D (WOS:000084699900021) 2000; 18
Juliano, R (WOS:000266652600005) 2009; 6
Deleavey, GF (WOS:000309152500006) 2012; 19
Wender, PA (WOS:000254068000003) 2008; 60
Koppelhus, U (WOS:000176064800001) 2002; 12
Escriou, V (WOS:000071507800012) 1998; 1368
Li, NS (WOS:000298575400003) 2011; 44
Hemmi, H (WOS:000165815200054) 2000; 408
Arora, V (WOS:000224302900005) 2004; 5
Dias, N (WOS:000178737000007) 2002; 1
BARBER, I (WOS:A1995QN51900007) 1995; 5
Nuutila, J (WOS:000229353200001) 2005; 65A
Labas, R (WOS:000273084000001) 2010; 138
Hassane, FS (WOS:000274655600004) 2010; 67
Elkins, KL (WOS:000078510800054) 1999; 162
Michel, T (WOS:000185353200008) 2003; 31
Grajkowski, A (WOS:000243735500017) 2007; 72
Mitchell, DJ (WOS:000165173900006) 2000; 56
Prater, CE (WOS:000221563300009) 2004; 15
TONKINSON, JL (WOS:A1994PQ22000035) 1994; 22
Lebedeva, I (WOS:000168439400016) 2001; 41
Wender, PA (WOS:000165476300022) 2000; 97
Ohmichi, T (WOS:000232958100007) 2005; 44
Kurreck, J (WOS:000182118800003) 2003; 270
Tung, CH (WOS:000089558300001) 2000; 11
Barber (10.1016/j.bmc.2013.04.071_b0100) 1995; 5
Watts (10.1016/j.bmc.2013.04.071_b0010) 2012; 226
Michel (10.1016/j.bmc.2013.04.071_b0090) 2003; 31
Deglane (10.1016/j.bmc.2013.04.071_b0085) 2006; 7
Arora (10.1016/j.bmc.2013.04.071_b0160) 2004; 5
Guy-Caffey (10.1016/j.bmc.2013.04.071_b0140) 1995; 270
Prater (10.1016/j.bmc.2013.04.071_b0060) 2004; 15
Manoharan (10.1016/j.bmc.2013.04.071_b0095) 2002; 12
Juliano (10.1016/j.bmc.2013.04.071_b0035) 2009; 6
Elkins (10.1016/j.bmc.2013.04.071_b0125) 1999; 162
Nuutila (10.1016/j.bmc.2013.04.071_b0145) 2005; 65A
Tonkinson (10.1016/j.bmc.2013.04.071_b0150) 1994; 22
Wender (10.1016/j.bmc.2013.04.071_b0075) 2000; 97
Mitchell (10.1016/j.bmc.2013.04.071_b0175) 2000; 56
Khalil (10.1016/j.bmc.2013.04.071_b0020) 2006; 58
Bally (10.1016/j.bmc.2013.04.071_b0030) 1999; 38
Grajkowski (10.1016/j.bmc.2013.04.071_b0115) 2001; 3
Said Hassane (10.1016/j.bmc.2013.04.071_b0055) 2010; 67
Escriou (10.1016/j.bmc.2013.04.071_b0180) 1998; 1368
Bologna (10.1016/j.bmc.2013.04.071_b0105) 2002; 12
Grajkowski (10.1016/j.bmc.2013.04.071_b0120) 2005; 33
Li (10.1016/j.bmc.2013.04.071_b0045) 2011; 44
Vivès (10.1016/j.bmc.2013.04.071_b0110) 1999; 27
Grajkowski (10.1016/j.bmc.2013.04.071_b0170) 2007; 72
Lebedeva (10.1016/j.bmc.2013.04.071_b0040) 2001; 41
Hemmi (10.1016/j.bmc.2013.04.071_b0130) 2000; 408
Luo (10.1016/j.bmc.2013.04.071_b0050) 2000; 18
Kurreck (10.1016/j.bmc.2013.04.071_b0015) 2003; 270
Nishimura (10.1016/j.bmc.2013.04.071_b0135) 2005; 28
Ming (10.1016/j.bmc.2013.04.071_b0025) 2011; 8
Deleavey (10.1016/j.bmc.2013.04.071_b0005) 2012; 19
Ohmichi (10.1016/j.bmc.2013.04.071_b0080) 2005; 44
Koppelhus (10.1016/j.bmc.2013.04.071_b0155) 2002; 12
Wender (10.1016/j.bmc.2013.04.071_b0070) 2008; 60
Tung (10.1016/j.bmc.2013.04.071_b0065) 2000; 11
Litzinger (10.1016/j.bmc.2013.04.071_b0190) 1997; 7
Dias (10.1016/j.bmc.2013.04.071_b0165) 2002; 1
Labas (10.1016/j.bmc.2013.04.071_b0185) 2010; 138
References_xml – volume: 38
  start-page: 291
  year: 1999
  ident: b0030
  contributor:
    fullname: Reimer
– volume: 31
  start-page: 5282
  year: 2003
  ident: b0090
  publication-title: Nucleic Acids Res.
  contributor:
    fullname: Vasseur
– volume: 27
  start-page: 4071
  year: 1999
  ident: b0110
  publication-title: Nucleic Acids Res.
  contributor:
    fullname: Imbach
– volume: 8
  start-page: 435
  year: 2011
  ident: b0025
  publication-title: Expert Opin. Drug Deliv.
  contributor:
    fullname: Ming
– volume: 97
  start-page: 13003
  year: 2000
  ident: b0075
  publication-title: Proc. Natl. Acad. Sci. U.S.A.
  contributor:
    fullname: Rothbard
– volume: 3
  start-page: 1287
  year: 2001
  ident: b0115
  publication-title: Org. Lett.
  contributor:
    fullname: Beaucage
– volume: 1368
  start-page: 276
  year: 1998
  ident: b0180
  publication-title: Biochim. Biophys. Acta
  contributor:
    fullname: Wils
– volume: 12
  start-page: 51
  year: 2002
  ident: b0155
  publication-title: .
  contributor:
    fullname: Nielsen
– volume: 56
  start-page: 318
  year: 2000
  ident: b0175
  publication-title: J. Pept. Res.
  contributor:
    fullname: Rothbard
– volume: 60
  start-page: 452
  year: 2008
  ident: b0070
  publication-title: Adv. Drug Delivery Rev.
  contributor:
    fullname: Pillow
– volume: 22
  start-page: 4268
  year: 1994
  ident: b0150
  publication-title: .
  contributor:
    fullname: Stein
– volume: 138
  start-page: 153
  year: 2010
  ident: b0185
  publication-title: Genetica
  contributor:
    fullname: Pitard
– volume: 65A
  start-page: 93
  year: 2005
  ident: b0145
  publication-title: Cytometry Part A
  contributor:
    fullname: Lilius
– volume: 162
  start-page: 2291
  year: 1999
  ident: b0125
  publication-title: J. Immunol.
  contributor:
    fullname: Klinman
– volume: 12
  start-page: 33
  year: 2002
  ident: b0105
  publication-title: .
  contributor:
    fullname: Morvan
– volume: 7
  start-page: 684
  year: 2006
  ident: b0085
  publication-title: ChemBioChem
  contributor:
    fullname: Vasseur
– volume: 270
  start-page: 1628
  year: 2003
  ident: b0015
  publication-title: .
  contributor:
    fullname: Kurreck
– volume: 11
  start-page: 605
  year: 2000
  ident: b0065
  publication-title: Bioconjugate Chem.
  contributor:
    fullname: Stein
– volume: 5
  start-page: 431
  year: 2004
  ident: b0160
  publication-title: .
  contributor:
    fullname: Iversen
– volume: 28
  start-page: 886
  year: 2005
  ident: b0135
  publication-title: .
  contributor:
    fullname: Naito
– volume: 12
  start-page: 103
  year: 2002
  ident: b0095
  publication-title: Antisense Nucleic Acid Drug Dev.
  contributor:
    fullname: Manoharan
– volume: 41
  start-page: 403
  year: 2001
  ident: b0040
  publication-title: Annu. Rev. Pharmacol.
  contributor:
    fullname: Stein
– volume: 44
  start-page: 6682
  year: 2005
  ident: b0080
  publication-title: Angew. Chem., Int. Ed.
  contributor:
    fullname: Sugimoto
– volume: 15
  start-page: 498
  year: 2004
  ident: b0060
  publication-title: Bioconjugate Chem.
  contributor:
    fullname: Miller
– volume: 33
  start-page: 3550
  year: 2005
  ident: b0120
  publication-title: .
  contributor:
    fullname: Beaucage
– volume: 226
  start-page: 365
  year: 2012
  ident: b0010
  publication-title: J. Pathol.
  contributor:
    fullname: Corey
– volume: 19
  start-page: 937
  year: 2012
  ident: b0005
  publication-title: Chem. Biol.
  contributor:
    fullname: Damha
– volume: 18
  start-page: 33
  year: 2000
  ident: b0050
  contributor:
    fullname: Saltzman
– volume: 67
  start-page: 715
  year: 2010
  ident: b0055
  publication-title: Cell. Mol. Life Sci.
  contributor:
    fullname: Lebleu
– volume: 1
  start-page: 347
  year: 2002
  ident: b0165
  publication-title: Mol. Cancer Ther.
  contributor:
    fullname: Stein
– volume: 72
  start-page: 805
  year: 2007
  ident: b0170
  publication-title: J. Org. Chem.
  contributor:
    fullname: Beaucage
– volume: 408
  start-page: 740
  year: 2000
  ident: b0130
  publication-title: Nat. Biotechnol.
  contributor:
    fullname: Akira
– volume: 5
  start-page: 563
  year: 1995
  ident: b0100
  publication-title: .
  contributor:
    fullname: Imbach
– volume: 58
  start-page: 32
  year: 2006
  ident: b0020
  publication-title: Pharmacol. Rev.
  contributor:
    fullname: Harashima
– volume: 270
  start-page: 31391
  year: 1995
  ident: b0140
  publication-title: J. Biol. Chem.
  contributor:
    fullname: Chaudhary
– volume: 7
  start-page: 51
  year: 1997
  ident: b0190
  publication-title: J. Liposome Res.
  contributor:
    fullname: Litzinger
– volume: 6
  start-page: 686
  year: 2009
  ident: b0035
  publication-title: Mol. Pharm.
  contributor:
    fullname: Ming
– volume: 44
  start-page: 1257
  year: 2011
  ident: b0045
  publication-title: Acc. Chem. Res.
  contributor:
    fullname: Piccirilli
– volume: 44
  start-page: 6682
  year: 2005
  ident: WOS:000232958100007
  article-title: Nucleic acid with guanidinium modification exhibits efficient cellular uptake
  publication-title: ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
  doi: 10.1002/anie.200500904
  contributor:
    fullname: Ohmichi, T
– volume: 72
  start-page: 805
  year: 2007
  ident: WOS:000243735500017
  article-title: Solid-phase synthesis of thermolytic DNA oligonucleotides functionalized with a single 4-hydroxy-1-butyl or 4-phosphato-/thiophosphato-1-butyl thiophosphate protecting group
  publication-title: JOURNAL OF ORGANIC CHEMISTRY
  doi: 10.1021/jo062087y
  contributor:
    fullname: Grajkowski, A
– volume: 1
  start-page: 347
  year: 2002
  ident: WOS:000178737000007
  article-title: Antisense oligonucleotides: Basic concepts and mechanisms
  publication-title: MOLECULAR CANCER THERAPEUTICS
  contributor:
    fullname: Dias, N
– volume: 11
  start-page: 605
  year: 2000
  ident: WOS:000089558300001
  article-title: Preparation and applications of peptide-oligonucleotide conjugates
  publication-title: BIOCONJUGATE CHEMISTRY
  contributor:
    fullname: Tung, CH
– volume: 60
  start-page: 452
  year: 2008
  ident: WOS:000254068000003
  article-title: The design of guanidinium-rich transporters and their internalization mechanisms
  publication-title: ADVANCED DRUG DELIVERY REVIEWS
  doi: 10.1016/j.addr.2007.10.016
  contributor:
    fullname: Wender, PA
– volume: 408
  start-page: 740
  year: 2000
  ident: WOS:000165815200054
  article-title: A Toll-like receptor recognizes bacterial DNA
  publication-title: NATURE
  contributor:
    fullname: Hemmi, H
– volume: 15
  start-page: 498
  year: 2004
  ident: WOS:000221563300009
  article-title: 3 '-methyphosphate-modified oligo-2 '-O-methylribonucleotides and their tat peptide conjugates: Uptake and stability in mouse fibroblasts in culture
  publication-title: BIOCONJUGATE CHEMISTRY
  doi: 10.1021/bc049977+
  contributor:
    fullname: Prater, CE
– volume: 3
  start-page: 1287
  year: 2001
  ident: WOS:000168395400011
  article-title: The 2-(N-formyl-N-methyl)aminoethyl group as a potential phosphate/thiophosphate protecting group in solid-phase oligodeoxyribonucleotide synthesis
  publication-title: ORGANIC LETTERS
  contributor:
    fullname: Grajkowski, A
– volume: 44
  start-page: 1257
  year: 2011
  ident: WOS:000298575400003
  article-title: Synthesis, Properties, and Applications of Oligonucleotides Containing an RNA Dinucleotide Phosphorothiolate Linkage
  publication-title: ACCOUNTS OF CHEMICAL RESEARCH
  doi: 10.1021/ar200131t
  contributor:
    fullname: Li, NS
– volume: 270
  start-page: 31391
  year: 1995
  ident: WOS:A1995TN44400080
  article-title: Novel polyaminolipids enhance the cellular uptake of oligonucleotides
  publication-title: JOURNAL OF BIOLOGICAL CHEMISTRY
  contributor:
    fullname: GuyCaffey, JK
– volume: 19
  start-page: 937
  year: 2012
  ident: WOS:000309152500006
  article-title: Designing Chemically Modified Oligonucleotides for Targeted Gene Silencing
  publication-title: CHEMISTRY & BIOLOGY
  doi: 10.1016/j.chembiol.2012.07.011
  contributor:
    fullname: Deleavey, GF
– volume: 8
  start-page: 435
  year: 2011
  ident: WOS:000288549600004
  article-title: Cellular delivery of siRNA and antisense oligonucleotides via receptor-mediated endocytosis
  publication-title: EXPERT OPINION ON DRUG DELIVERY
  doi: 10.1517/17425247.2011.561313
  contributor:
    fullname: Ming, X
– volume: 67
  start-page: 715
  year: 2010
  ident: WOS:000274655600004
  article-title: Cell penetrating peptides: overview and applications to the delivery of oligonucleotides
  publication-title: CELLULAR AND MOLECULAR LIFE SCIENCES
  doi: 10.1007/s00018-009-0186-0
  contributor:
    fullname: Hassane, FS
– volume: 56
  start-page: 318
  year: 2000
  ident: WOS:000165173900006
  article-title: Polyarginine enters cells more efficiently than other polycationic homopolymers
  publication-title: JOURNAL OF PEPTIDE RESEARCH
  contributor:
    fullname: Mitchell, DJ
– volume: 22
  start-page: 4268
  year: 1994
  ident: WOS:A1994PQ22000035
  article-title: PATTERNS OF INTRACELLULAR COMPARTMENTALIZATION, TRAFFICKING AND ACIDIFICATION OF 5'-FLUORESCEIN LABELED PHOSPHODIESTER AND PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES IN HL-60 CELLS
  publication-title: NUCLEIC ACIDS RESEARCH
  contributor:
    fullname: TONKINSON, JL
– volume: 28
  start-page: 886
  year: 2005
  ident: WOS:000229083600023
  article-title: Tissue-specific mRNA expression profiles of human toll-like receptors and related genes
  publication-title: BIOLOGICAL & PHARMACEUTICAL BULLETIN
  contributor:
    fullname: Nishimura, M
– volume: 12
  start-page: 51
  year: 2002
  ident: WOS:000176064800001
  article-title: Cell-dependent differential cellular uptake of PNA, peptides, and PNA-peptide conjugates
  publication-title: ANTISENSE & NUCLEIC ACID DRUG DEVELOPMENT
  contributor:
    fullname: Koppelhus, U
– volume: 41
  start-page: 403
  year: 2001
  ident: WOS:000168439400016
  article-title: Antisense oligonucleotides: Promise and reality
  publication-title: ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY
  contributor:
    fullname: Lebedeva, I
– volume: 7
  start-page: 51
  year: 1997
  ident: BCI:BCI199799461657
  article-title: Limitations of cationic liposomes for antisense oligonucleotide delivery in vivo
  publication-title: Journal of Liposome Research
  contributor:
    fullname: Litzinger, David C.
– volume: 18
  start-page: 33
  year: 2000
  ident: WOS:000084699900021
  article-title: Synthetic DNA delivery systems
  publication-title: NATURE BIOTECHNOLOGY
  contributor:
    fullname: Luo, D
– volume: 12
  start-page: 33
  year: 2002
  ident: WOS:000175215800004
  article-title: Uptake and quantification of intracellular concentration of lipophilic pro-oligonucleotides in HeLa cells
  publication-title: ANTISENSE & NUCLEIC ACID DRUG DEVELOPMENT
  contributor:
    fullname: Bologna, JC
– volume: 65A
  start-page: 93
  year: 2005
  ident: WOS:000229353200001
  article-title: Flow cytometric quantitative determination of ingestion by phagocytes needs the distinguishing of overlapping populations of binding and ingesting cells
  publication-title: CYTOMETRY PART A
  doi: 10.1002/cyto.a.20139
  contributor:
    fullname: Nuutila, J
– volume: 1368
  start-page: 276
  year: 1998
  ident: WOS:000071507800012
  article-title: Cationic lipid-mediated gene transfer: effect of serum on cellular uptake and intracellular fate of lipopolyamine/DNA complexes
  publication-title: BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
  contributor:
    fullname: Escriou, V
– volume: 33
  start-page: 3550
  year: 2005
  ident: WOS:000230345800017
  article-title: Thermolytic CpG-containing DNA oligonucleotides as potential immunotherapeutic prodrugs
  publication-title: NUCLEIC ACIDS RESEARCH
  doi: 10.1093/nar/gki657
  contributor:
    fullname: Grajkowski, A
– volume: 38
  start-page: 291
  year: 1999
  ident: WOS:000082371300007
  article-title: Biological barriers to cellular delivery of lipid-based DNA carriers
  publication-title: ADVANCED DRUG DELIVERY REVIEWS
  contributor:
    fullname: Bally, MB
– volume: 162
  start-page: 2291
  year: 1999
  ident: WOS:000078510800054
  article-title: Bacterial DNA containing CpG motifs stimulates lymphocyte-dependent protection of mice against lethal infection with intracellular bacteria
  publication-title: JOURNAL OF IMMUNOLOGY
  contributor:
    fullname: Elkins, KL
– volume: 5
  start-page: 431
  year: 2004
  ident: WOS:000224302900005
  article-title: Neutrally charged phosphorodiamidate morpholino antisense oligomers: Uptake, efficacy and pharmacokinetics
  publication-title: CURRENT PHARMACEUTICAL BIOTECHNOLOGY
  contributor:
    fullname: Arora, V
– volume: 27
  start-page: 4071
  year: 1999
  ident: WOS:000083201400015
  article-title: Lipophilic pro-oligonucleotides are rapidly and efficiently internalized in HeLa cells
  publication-title: NUCLEIC ACIDS RESEARCH
  contributor:
    fullname: Vives, E
– volume: 270
  start-page: 1628
  year: 2003
  ident: WOS:000182118800003
  article-title: Antisense technologies - Improvement through novel chemical modifications
  publication-title: EUROPEAN JOURNAL OF BIOCHEMISTRY
  doi: 10.1046/j.1432-1033.2003.03555.x
  contributor:
    fullname: Kurreck, J
– volume: 12
  start-page: 103
  year: 2002
  ident: WOS:000176064800006
  article-title: Oligonucleotide conjugates as potential antisense drugs with improved uptake, biodistribution, targeted delivery, and mechanism of action
  publication-title: ANTISENSE & NUCLEIC ACID DRUG DEVELOPMENT
  contributor:
    fullname: Manoharan, M
– volume: 138
  start-page: 153
  year: 2010
  ident: WOS:000273084000001
  article-title: Nature as a source of inspiration for cationic lipid synthesis
  publication-title: GENETICA
  doi: 10.1007/s10709-009-9405-8
  contributor:
    fullname: Labas, R
– volume: 226
  start-page: 365
  year: 2012
  ident: WOS:000299157600018
  article-title: Silencing disease genes in the laboratory and the clinic
  publication-title: JOURNAL OF PATHOLOGY
  doi: 10.1002/path.2993
  contributor:
    fullname: Watts, JK
– volume: 97
  start-page: 13003
  year: 2000
  ident: WOS:000165476300022
  article-title: The design, synthesis, and evaluation of molecules that enable or enhance cellular uptake: Peptoid molecular transporters
  publication-title: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
  contributor:
    fullname: Wender, PA
– volume: 58
  start-page: 32
  year: 2006
  ident: WOS:000235683400005
  article-title: Uptake pathways and subsequent intracellular trafficking in nonviral gene delivery
  publication-title: PHARMACOLOGICAL REVIEWS
  doi: 10.1124/pr.58.1.8
  contributor:
    fullname: Khalil, IA
– volume: 31
  start-page: 5282
  year: 2003
  ident: WOS:000185353200008
  article-title: Cationic phosphoramidate alpha-oligonucleotides efficiently target single-stranded DNA and RNA and inhibit hepatitis C virus IRES-mediated translation
  publication-title: NUCLEIC ACIDS RESEARCH
  doi: 10.1093/nar/gkg733
  contributor:
    fullname: Michel, T
– volume: 5
  start-page: 563
  year: 1995
  ident: WOS:A1995QN51900007
  article-title: THE PROOLIGONUCLEOTIDE APPROACH .1. ESTERASE-MEDIATED REVERSIBILITY OF DITHYMIDINE-S-ALKYL-PHOSPHOROTHIOLATES TO DITHYMIDINE PHOSPHOROTHIOATES
  publication-title: BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
  contributor:
    fullname: BARBER, I
– volume: 6
  start-page: 686
  year: 2009
  ident: WOS:000266652600005
  article-title: Biological Barriers to Therapy with Antisense and siRNA Oligonucleotides
  publication-title: MOLECULAR PHARMACEUTICS
  doi: 10.1021/mp900093r
  contributor:
    fullname: Juliano, R
– volume: 7
  start-page: 684
  year: 2006
  ident: WOS:000236685900019
  article-title: Impact of the guanidinium group on hybridization and cellular uptake of cationic oligonucleotides
  publication-title: CHEMBIOCHEM
  doi: 10.1002/cbic.200500433
  contributor:
    fullname: Deglane, G
– volume: 7
  start-page: 684
  year: 2006
  ident: 10.1016/j.bmc.2013.04.071_b0085
  publication-title: ChemBioChem
  doi: 10.1002/cbic.200500433
  contributor:
    fullname: Deglane
– volume: 12
  start-page: 33
  year: 2002
  ident: 10.1016/j.bmc.2013.04.071_b0105
  publication-title: Antisense Nucleic Acid Drug Dev.
  doi: 10.1089/108729002753670247
  contributor:
    fullname: Bologna
– volume: 3
  start-page: 1287
  year: 2001
  ident: 10.1016/j.bmc.2013.04.071_b0115
  publication-title: Org. Lett.
  doi: 10.1021/ol0156852
  contributor:
    fullname: Grajkowski
– volume: 7
  start-page: 51
  year: 1997
  ident: 10.1016/j.bmc.2013.04.071_b0190
  publication-title: J. Liposome Res.
  doi: 10.3109/08982109709035481
  contributor:
    fullname: Litzinger
– volume: 18
  start-page: 33
  year: 2000
  ident: 10.1016/j.bmc.2013.04.071_b0050
  publication-title: Nat. Biotechnol.
  doi: 10.1038/78523
  contributor:
    fullname: Luo
– volume: 33
  start-page: 3550
  year: 2005
  ident: 10.1016/j.bmc.2013.04.071_b0120
  publication-title: Nucleic Acids Res.
  doi: 10.1093/nar/gki657
  contributor:
    fullname: Grajkowski
– volume: 8
  start-page: 435
  year: 2011
  ident: 10.1016/j.bmc.2013.04.071_b0025
  publication-title: Expert Opin. Drug Deliv.
  doi: 10.1517/17425247.2011.561313
  contributor:
    fullname: Ming
– volume: 5
  start-page: 563
  year: 1995
  ident: 10.1016/j.bmc.2013.04.071_b0100
  publication-title: Bioorg. Med. Chem. Lett.
  doi: 10.1016/0960-894X(95)00074-4
  contributor:
    fullname: Barber
– volume: 226
  start-page: 365
  year: 2012
  ident: 10.1016/j.bmc.2013.04.071_b0010
  publication-title: J. Pathol.
  doi: 10.1002/path.2993
  contributor:
    fullname: Watts
– volume: 97
  start-page: 13003
  year: 2000
  ident: 10.1016/j.bmc.2013.04.071_b0075
  publication-title: Proc. Natl. Acad. Sci. U.S.A.
  doi: 10.1073/pnas.97.24.13003
  contributor:
    fullname: Wender
– volume: 12
  start-page: 103
  year: 2002
  ident: 10.1016/j.bmc.2013.04.071_b0095
  publication-title: Antisense Nucleic Acid Drug Dev.
  doi: 10.1089/108729002760070849
  contributor:
    fullname: Manoharan
– volume: 44
  start-page: 1257
  year: 2011
  ident: 10.1016/j.bmc.2013.04.071_b0045
  publication-title: Acc. Chem. Res.
  doi: 10.1021/ar200131t
  contributor:
    fullname: Li
– volume: 27
  start-page: 4071
  year: 1999
  ident: 10.1016/j.bmc.2013.04.071_b0110
  publication-title: Nucleic Acids Res.
  doi: 10.1093/nar/27.20.4071
  contributor:
    fullname: Vivès
– volume: 31
  start-page: 5282
  year: 2003
  ident: 10.1016/j.bmc.2013.04.071_b0090
  publication-title: Nucleic Acids Res.
  doi: 10.1093/nar/gkg733
  contributor:
    fullname: Michel
– volume: 38
  start-page: 291
  year: 1999
  ident: 10.1016/j.bmc.2013.04.071_b0030
  publication-title: Adv. Drug Delivery Rev.
  doi: 10.1016/S0169-409X(99)00034-4
  contributor:
    fullname: Bally
– volume: 19
  start-page: 937
  year: 2012
  ident: 10.1016/j.bmc.2013.04.071_b0005
  publication-title: Chem. Biol.
  doi: 10.1016/j.chembiol.2012.07.011
  contributor:
    fullname: Deleavey
– volume: 58
  start-page: 32
  year: 2006
  ident: 10.1016/j.bmc.2013.04.071_b0020
  publication-title: Pharmacol. Rev.
  doi: 10.1124/pr.58.1.8
  contributor:
    fullname: Khalil
– volume: 6
  start-page: 686
  year: 2009
  ident: 10.1016/j.bmc.2013.04.071_b0035
  publication-title: Mol. Pharm.
  doi: 10.1021/mp900093r
  contributor:
    fullname: Juliano
– volume: 11
  start-page: 605
  year: 2000
  ident: 10.1016/j.bmc.2013.04.071_b0065
  publication-title: Bioconjugate Chem.
  doi: 10.1021/bc0000334
  contributor:
    fullname: Tung
– volume: 1
  start-page: 347
  year: 2002
  ident: 10.1016/j.bmc.2013.04.071_b0165
  publication-title: Mol. Cancer Ther.
  doi: 10.4161/cbt.1.4.4
  contributor:
    fullname: Dias
– volume: 60
  start-page: 452
  year: 2008
  ident: 10.1016/j.bmc.2013.04.071_b0070
  publication-title: Adv. Drug Delivery Rev.
  doi: 10.1016/j.addr.2007.10.016
  contributor:
    fullname: Wender
– volume: 5
  start-page: 431
  year: 2004
  ident: 10.1016/j.bmc.2013.04.071_b0160
  publication-title: Curr. Pharm. Biotechnol.
  doi: 10.2174/1389201043376706
  contributor:
    fullname: Arora
– volume: 41
  start-page: 403
  year: 2001
  ident: 10.1016/j.bmc.2013.04.071_b0040
  publication-title: Annu. Rev. Pharmacol.
  doi: 10.1146/annurev.pharmtox.41.1.403
  contributor:
    fullname: Lebedeva
– volume: 270
  start-page: 31391
  year: 1995
  ident: 10.1016/j.bmc.2013.04.071_b0140
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.270.52.31391
  contributor:
    fullname: Guy-Caffey
– volume: 12
  start-page: 51
  year: 2002
  ident: 10.1016/j.bmc.2013.04.071_b0155
  publication-title: Antisense Nucleic Acid Drug Dev.
  doi: 10.1089/108729002760070795
  contributor:
    fullname: Koppelhus
– volume: 22
  start-page: 4268
  year: 1994
  ident: 10.1016/j.bmc.2013.04.071_b0150
  publication-title: Nucleic Acids Res.
  doi: 10.1093/nar/22.20.4268
  contributor:
    fullname: Tonkinson
– volume: 408
  start-page: 740
  year: 2000
  ident: 10.1016/j.bmc.2013.04.071_b0130
  publication-title: Nat. Biotechnol.
  contributor:
    fullname: Hemmi
– volume: 270
  start-page: 1628
  year: 2003
  ident: 10.1016/j.bmc.2013.04.071_b0015
  publication-title: Eur. J. Biochem.
  doi: 10.1046/j.1432-1033.2003.03555.x
  contributor:
    fullname: Kurreck
– volume: 162
  start-page: 2291
  year: 1999
  ident: 10.1016/j.bmc.2013.04.071_b0125
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.162.4.2291
  contributor:
    fullname: Elkins
– volume: 67
  start-page: 715
  year: 2010
  ident: 10.1016/j.bmc.2013.04.071_b0055
  publication-title: Cell. Mol. Life Sci.
  doi: 10.1007/s00018-009-0186-0
  contributor:
    fullname: Said Hassane
– volume: 72
  start-page: 805
  year: 2007
  ident: 10.1016/j.bmc.2013.04.071_b0170
  publication-title: J. Org. Chem.
  doi: 10.1021/jo062087y
  contributor:
    fullname: Grajkowski
– volume: 138
  start-page: 153
  year: 2010
  ident: 10.1016/j.bmc.2013.04.071_b0185
  publication-title: Genetica
  doi: 10.1007/s10709-009-9405-8
  contributor:
    fullname: Labas
– volume: 44
  start-page: 6682
  year: 2005
  ident: 10.1016/j.bmc.2013.04.071_b0080
  publication-title: Angew. Chem., Int. Ed.
  doi: 10.1002/anie.200500904
  contributor:
    fullname: Ohmichi
– volume: 1368
  start-page: 276
  year: 1998
  ident: 10.1016/j.bmc.2013.04.071_b0180
  publication-title: Biochim. Biophys. Acta
  doi: 10.1016/S0005-2736(97)00194-6
  contributor:
    fullname: Escriou
– volume: 15
  start-page: 498
  year: 2004
  ident: 10.1016/j.bmc.2013.04.071_b0060
  publication-title: Bioconjugate Chem.
  doi: 10.1021/bc049977+
  contributor:
    fullname: Prater
– volume: 28
  start-page: 886
  year: 2005
  ident: 10.1016/j.bmc.2013.04.071_b0135
  publication-title: Biol. Pharm. Bull.
  doi: 10.1248/bpb.28.886
  contributor:
    fullname: Nishimura
– volume: 65A
  start-page: 93
  year: 2005
  ident: 10.1016/j.bmc.2013.04.071_b0145
  publication-title: Cytometry Part A
  doi: 10.1002/cyto.a.20139
  contributor:
    fullname: Nuutila
– volume: 56
  start-page: 318
  year: 2000
  ident: 10.1016/j.bmc.2013.04.071_b0175
  publication-title: J. Pept. Res.
  doi: 10.1034/j.1399-3011.2000.00723.x
  contributor:
    fullname: Mitchell
SSID ssj0002491
Score 2.1891904
Snippet The bioactivity of a CpG-containing phosphorothioate DNA oligonucleotide with thermolytic 2-(N-formyl-N-methylamino)ethyl (fma) thiophosphate groups in mice...
The bioactivity of a CpG-containing phosphorothioate DNA oligonucleotide with thermolytic 2-(N-formyl-N-methylamino) ethyl (fma) thiophosphate groups in mice...
Source Web of Science
SourceID proquest
crossref
pubmed
webofscience
fao
elsevier
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 6224
SubjectTerms Animals
Biochemistry & Molecular Biology
Cellular internalization
Cercopithecus aethiops
Chemistry
Chemistry, Medicinal
Chemistry, Organic
cytotoxicity
DNA
DNA - chemistry
DNA - pharmacokinetics
drugs
flow cytometry
Fluoresceins - chemistry
fma-Thiophosphate protecting group
HeLa Cells
Humans
Life Sciences & Biomedicine
Lipids - chemistry
Lipids - pharmacokinetics
Mice
microscopy
Microscopy, Confocal
Nuclear localization
Nucleic acid-based drug delivery
nucleotide sequences
oligonucleotides
Oligonucleotides - chemistry
Oligonucleotides - pharmacokinetics
Pharmacology & Pharmacy
Physical Sciences
Positively charged DNA prodrug
Prodrugs - pharmacokinetics
Science & Technology
Thermolytic DNA prodrugs
Thionucleotides - chemistry
Thionucleotides - pharmacokinetics
thiophosphate
Vero Cells
Title Assessment of the cellular internalization of thermolytic phosphorothioate DNA oligonucleotide prodrugs
URI https://dx.doi.org/10.1016/j.bmc.2013.04.071
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestApp=WOS&DestLinkType=FullRecord&UT=000325162000019
https://www.ncbi.nlm.nih.gov/pubmed/23755885
https://search.proquest.com/docview/1443388690
https://search.proquest.com/docview/1520389344
Volume 21
WOS 000325162000019
WOSCitedRecordID wos000325162000019
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEB6VIgEXBClQF6gWqeKAZOLHrtc-WoEqgJpLidTbyuvspkaJN8rj0Au_vTN-BJBKhTjkkHjjJPtNZr5vdnYW4MwkpUliG_mFKClbJbSfZYXxg1midSqlKJtkzsUkGU_51ytxdQCjfi8MlVV2vr_16Y237l4ZdrM5XFXV8BLJdxqkGRHggIcB6XaOwQht-uPPX2UeKC-aU_NwsE-j-5XNpsZLL6mLYRg33U5l-LfY9MAW7i4GemewagLT-TN42jFKlrdf-jkcmHoAR3mNanp5w96zpsazSZ4P4PGoP99tAI8uumX1I5jn-_6czFmGnJBRQp8qVFnVpgwX3X7N7vp66RY3-IFsde02-Fgj4JVD3so-TXLmFtXc1dQp2W2rmWHkpde7-eYFTM8_fx-N_e4EBr_kMtn6aGbIn7SUKdIOrXkaFRwFxswmmY5lqDHshYW0KMilDSKdFrZEpBNrSyMFn5n4JRzWrjbHwHgpaQ9uZEOpkTTERYZWkonS4m1jkyYefOjnXq3aRhuqr0D7oRAoRUCpgCsEygPeo6P-sBaFgeC-tx0jkqqYo_9U08uIsj3o31Cmcw_e9fAqxIEmuaiN221QG3GU8XRw1z1jRESNCmOO93nV2sb-R0SxFCJNhQdnvxvL_jqpUiSZSdQstGQehP8ybNR1cKfOBduT_5uO1_CEnlEkDsUbONyud-YtUqytPm3-Q6fwMP_ybTy5BSlnIxM
link.rule.ids 315,786,790,4521,24144,27957,27958,45620,45714
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9swDCa6FFh3KbZ0W929NKDYYYARPyTLPhrZinRtcmkD9CZYjpR6SKwgj0P__ShbDjagK4YdfLHkl0iT30dRFMC5SkqVxDryC1baaBWTfpYVyg9miZQp56xsgjnjSTKa0h937O4Aht1aGJtW6Wx_a9Mba-3ODNxoDlZVNbhB8J0GaWYBcEDDAHn7IWU8pD04zC-vRpO9QUaG0Wych_19e0E3udmkecmlLWQYxk3BUx7-zT0904V5DIQ-6q8a33TxEo4dqCR5-96v4EDVfTjJayTUywfyhTRpnk38vA9Hw26Ltz48H7uZ9ROY5_sSncRogrCQ2Ji-TVIlVRs1XLglm659vTSLB3wgWd2bDR5rlHllELqSb5OcmEU1N7Utlmy21UwRa6jXu_nmNUwvvt8OR77bhMEvKU-2PmoaQijJeYrIQ0qaRgVFjjHTSSZjHkr0fGHBNXJyroNIpoUuUdiJ1qXijM5U_AZ6tanVKRBacrsMN9Ihl4gb4iJDRclYqfG2sUoTD752Yy9Wba0N0SWh_RQoKGEFJQIqUFAe0E464g-FEegLnrrsFCUpijmaUDG9iWzAB00cMnXqwedOvALlYAe5qJXZbZAeUWTydu-uJ_qwyNYqjCne522rG_uPiGLOWJoyD85_V5Z9uyWmiDOTqJlryTwI_6Xb0BVxt8ULtmf_Nxyf4Gh0O74W15eTq3fwwrZYxxyy99DbrnfqAyKurfzo_qhfJRUlyQ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Assessment+of+the+cellular+internalization+of+thermolytic+phosphorothioate+DNA+oligonucleotide+prodrugs&rft.jtitle=Bioorganic+%26+medicinal+chemistry&rft.au=Jain%2C+Harsh+V&rft.au=Takeda%2C+Kazuyo&rft.au=Tami%2C+Cecilia&rft.au=Verthelyi%2C+Daniela&rft.date=2013-10-15&rft.pub=Elsevier+Ltd&rft.issn=0968-0896&rft.eissn=1464-3391&rft.volume=21&rft.issue=20&rft.spage=6224&rft.epage=6232&rft_id=info:doi/10.1016%2Fj.bmc.2013.04.071&rft.externalDocID=US201500111334
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0968-0896&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0968-0896&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0968-0896&client=summon